Functional Wound Recovery in Amniotic Band Syndrome Via Personalized 3D Biomodels: The Case of the Ballet Dancer.

Adv Skin Wound CareJun 15, 2026 (epub)
Case ReportPlastic SurgeryOrthopedic Surgery

Miguel A Ceccarelli, Regina C Schechtman, Heron Werner et al.

✦ AI-curated · Sources linked

Case in brief

A 14-year-old ballet dancer with amniotic band syndrome presented with recurrent toe ulcerations, pain, and nail deformities. High-resolution MRI revealed complex forefoot abnormalities, leading to the design of a personalized 3D-printed prosthesis. Over one year, the patient experienced significant pain reduction and functional improvement, allowing her to resume ballet training without lesion recurrence.

Diagnostic / clinical pearl

MRI-guided 3D-printed prostheses can effectively address biomechanical challenges in patients with amniotic band syndrome, particularly in high-demand activities like ballet.

Why it matters

This case highlights the potential of personalized prosthetic solutions in enhancing functional recovery and pain management in patients with complex congenital conditions.

Source

PubMed · PMID 42296377

Published in Adv Skin Wound Care. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Plastic Surgery

Clinical ResearchHematology

Ponatinib-Blinatumomab or Imatinib-Chemotherapy for Adult Ph-Positive ALL.

This multicenter, phase 3 randomized trial compared frontline ponatinib plus blinatumomab with imatinib plus chemotherapy in adults with Philadelphia-positive acute lymphoblastic leukemia.

N Engl J MedOct 15, 2026Read summary
Clinical ResearchHematology

Efficacy and safety of mitapivat in patients with sickle cell disease (RISE UP): a phase 3, double-blind, global, randomised, placebo-controlled trial.

RISE UP was a phase 3, double-blind, global, randomised, placebo-controlled trial conducted at 69 sites in 15 countries. It evaluated twice-daily mitapivat in patients older than 16 years with sickle cell disease…

LancetOct 24, 2026Read summary
Clinical ResearchRheumatology

Ianalumab for the Treatment of Patients with Sjögren's Disease.

Two 52-week, double-blind, randomized, placebo-controlled phase III trials evaluated monthly or less frequent ianalumab in patients with active Sjögren's disease.

N Engl J MedOct 22, 2026Read summary

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text
Create my personalized digestSee plans

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.